Companies: 10,795·Total market cap: $144.5T

StageZero Life Sciences Ltd.

StageZero Life Sciences Ltd.

SZLSFOTCHealthcare● Active

$0.01

+$0.00(+0.00%)

Market Cap$630018

P/E Ratio—

52W High$0.03109

52W Low$0.0005

Avg Volume17

Open$0.01

Beta0.34

Net Income Financials Revenue

StageZero Life Sciences Ltd. (SZLSF) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

SZLSF · net income · updated Jun 15, 2026

Core profitability metrics

SZLSF · net income · margin · TTM · CAGR

Net income was −$11.4M for FY2022 (fiscal year ending 2022-12-31), down 52.5% year-over-year. Net profit margin was -300.8%.

FY2022 Net Income−$11.4M▼ -52.5% YoY

Trailing 12M (TTM)−$2.3Mtrailing 4 quarters sum

Net Profit Margin-300.8%−$11.4M ÷ $3.8M

YoY Change-52.5%—

5-Year CAGRN/AN/A — contains loss years

FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /income-statement · US GAAP · USDUpdated: Jun 15, 2026

Annual net income history

Net Income (bars) · Net Profit Margin % (line)

Net IncomeNet LossNet Margin %

▸ FMP /income-statement · Annual · SZLSF net income history · SZLSF profit margin

Annual net income data

SZLSF · net income history · annual / quarterly

Fiscal YearNet IncomeYoY ChangeNet MarginRevenue

FY2022Loss−$11.4M▼ 52.5%-300.8%$3.8M

FY2021Loss−$7.5M▼ 9.0%-147.7%$5.1M

FY2020Loss−$6.9M▼ 97.1%-165.3%$4.2M

FY2019Loss−$3.5M▲ +11.7%-2510.2%$138,704

FY2018Loss−$3.9M▼ 33.8%-2121.8%$185,874

Net income vs peers (Healthcare)

SZLSF vs peers · net income

#CompanyNet IncomeYoYNet MarginRelative

#1

StageZero Life Sciences Ltd.YOU

SZLSF

−$11.4M-52.5%-300.8%

Loss

Johnson & Johnson

$26.80B+90.6%28.5%

Eli Lilly and Company

$20.64B+94.9%31.7%

UnitedHealth Group Incorporated

$12.06B-16.3%2.7%

$4.23B-1.2%6.9%

Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

StageZero Life Sciences Ltd. (SZLSF) reported net income of −$11.4M for FY2022 (fiscal year ending 2022-12-31), down 52.5% year-over-year. The net profit margin was -300.8% — meaning the company kept $-3.01 of every dollar of revenue as profit.

StageZero Life Sciences Ltd. has not yet achieved annual profitability based on available data (15 fiscal years). The company has reported net losses across all available periods.

StageZero Life Sciences Ltd.'s net profit margin was -300.8% for FY2022, based on the latest annual results.

Investors sometimes search for "StageZero Life Sciences Ltd. net worth" — the company's market capitalization is a separate figure from SZLSF net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Revenue Financial statements Earnings Forecast Price history Market cap Free cash flow

Frequently asked questions

SZLSF net income · 4 questions

StageZero Life Sciences Ltd. is not currently profitable on an annual basis. The company reported a net loss of $11.4M for FY2022.

is SZLSF profitabledoes SZLSF make a profitSZLSF profitabilitySZLSF profitable company

▸ Source: FMP /income-statement · GAAP · StageZero Life Sciences Ltd. · StageZero Life Sciences Ltd. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 15, 2026